BlackRock Advisors’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	$184K	Buy	6,784 +2,234	+49%	+$60.6K	﹤0.01%	2686
2016 Q3	$117K	Buy	4,550 +1,686	+59%	+$43.4K	﹤0.01%	2888
2016 Q2	$53K	Buy	2,864 +927	+48%	+$17.2K	﹤0.01%	3156
2016 Q1	$37K	Hold	1,937	–	–	﹤0.01%	3195
2015 Q4	$52K	Buy	+1,937	New	+$52K	﹤0.01%	3120